via The Scientist RSS https://ift.tt/3ilk79U Targeted cancer therapy may jeopardize the effectiveness of subsequent immunotherapy by reducing dendritic cell numbers and activation, according to study of mice and patient samples. https://ift.tt/eA8V8J July 16, 2021 at 07:35PM